WAT Medical Enterprise Ltd. of Vancouver at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair
Manufacturers

WAT Medical Enterprise Ltd.

Unit 170, 422 Richards St., V6B 2Z4 Vancouver
Canada

Telephone +1 604 385-0656
Fax +1 604 448-3008
rayjby@hotmail.com

This company is co-exhibitor of
Canadian German Chamber of Industry and Commerce Inc.

Hall map

MEDICA 2017 hall map (Hall 16): stand F46

Fairground map

MEDICA 2017 fairground map: Hall 16

Contact

Raymond Ji

CEO

V6B 2Z4 Vancouver

Phone
86-18317139069

Email
watmed@hotmail.com

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.03  Therapie and physical medicine
  • 01.03.02  Electro-therapy equipment

Electro-therapy equipment

Our products

Product category: Electro-therapy equipment

EmeTerm

  • Wanna travel but concerned about seasickness and carsickness?
  • Wanna enjoy the sights from a mountain but altitude sickness just kills your desire?
  • Wanna expreince a VR but worried about dizziness.
Nausea and vomiting are common symptoms for many people while driving or traveling by cars, boats, or airplanes, and for many women who are pregnant and experience morning sickness; also, Chemotherapy medicines can induce nausea as well as playing with VR devices.

While many people take medicines to contrast those symptoms, some people choose to endure them because they do not want to experience the negative side effects of the medicines, which may at times be even worse than what it is meant to treat.

With Electrical antiemtic partner device, all your worries will be gone! EmeTerm is a clinically proven, safe and effective anti-nausea wristband that prevents and relieves nausea and vomiting induced by motion sickness (while traveling by car, boat, or plane and VR induced sickness), morning sickness (during pregnancy) and sickness induced by medicines.

Principle:Nausea and vomiting are caused by the transmission of a nausea signal to the stomach via the human brain, which causes the stomach to contrast irregularly, resulting in vomiting. By releasing a low-frequency pulse with a particular frequency.EmeTerm can adjust the vagues nerve signals traveling to and from the stomach, and can prevent or postpone the brain from transmitting nausea signals to the stomach. This slows down the irregular gastric contractions, and reduces the nauseous sensation for the users.

More Less

Product category: Electro-therapy equipment

HeadaTerm

  •  Do you want to get rid of the one-sided throbbing pain in your head and of associated nausea and visual problem?
  • Do you want migraines to stop affecting your professional and personal lives?
Primary headaches are debilitating conditions that are extremely common among people. Drug treatments are the popular solutions to many patients, but just like with anti-nausea drugs, there are side effects that often turn people away. 
Then, our bestselling HeadaTerm is definitely for you! No drug, no risk, no worries about potential side-effect.

HeadaTerm offers a drug-free scheme, which introduces electric impulses to act on the supraorbital nerve and supratrochlear nerve, the very nerves that transmit migraine pain, to treat and prevent migraine headaches.

HeadaTerm enables an electronic feedback mechanism to adjust the electrical impulses to the specific requirements of the individual user for personalized efficacy and comfort.

Primary headaches, like migraine, are transmitted by the supraorbital nerve and the supratrochlear nerve. HeadaTerm introduces electric impulses from the user's forehead to act on these nerves and reduce the migraine signals transmitted. The device avoids any drug effects, making it appropriate a wide range of users. Every device contains 21 rounds of standard therapies, each therapy lasts 20 minutes.

HeadaTerm is very small and light, making it convenient not only to use at home or at the office, but also on trips and outdoor travelling.

More Less

Company news

Date

Topic

Download

Jun 28, 2018

HeadaTerm (TM): The Cost Would Not Add Pain to Migraine Patients

VANCOUVER, Canada, July 28, 2017 /PRNewswire/ -- Cost Can be a Major Roadblock in Migraine Therapy

The team from migraine.com conducted a survey in 2016 titled: "Migraine in America" with the goal to gain a better understanding of the challenges faced by migraine patients. Over 3,900 people completed the 145-question survey.

he results show that:

Over 36% of the patients spent over $1,000 per year on migraine related treatments.
64% of the patients have avoided therapy because of the cost.
62% of the patients asked their doctors for cheaper prescriptions.
50% of the patients skipped entire dosages to make their prescriptions last longer.

The impact of migraine on one's life can be overwhelming and far-reaching, negatively affecting personal relationships, ability to work or to attend school.

HeadaTerm principle

HeadaTerm uses none-invasive external Trigeminal Nerve Stimulation (eTNS) technology that introduces precise electric impulses from the user's forehead to act on the supratrochlear nerves and reduce the migraine signals transmitted. The device avoids any drug effects, making it appropriate a wide range of users. eTNS has been clinically used for migraine and other conditions for over 40 years and was proven to be safety and effective.

What HeadaTerm contributed is making the therapy affordable - the device is low cost and it reduces the consume of medications. HeadaTerm is particularly helpful for sufferers with frequent migraine. The usage of medications would be reduced and the patient's quality of life to be improved.

The product design is usability-based. Very portable design makes the therapy available at any place any time. LED light and buzzer indicates the status of device and keeps communicating with user. Easy shutter. Attached mirror helps user to position device. Arc-shaped device match easily with forehead.

HeadaTerm has medical level standard. It's CE-certified medical device to prevent and treat primary headache. It is estimated to be approved by FDA and Health Canada by early 2018. The manufacturer, WAT Medical, is certified to the ISO medical standard.

Low Cost Solution

HeadaTerm costs $29.00 per device. One device contains 21 rounds of standard therapies; each therapy lasts 20 minutes. HeadaTerm is designed to be an affordable innovative technology that provides access to a drug-free treatment for primary headaches.

For more information, please visit WAT Medical Enterprise Ltd.'s website at www.watmedical.com or email info@watmedical.com

References:

1,https://www.ncbi.nlm.nih.gov/pubmed/16095269
2.http://www.who.int/healthinfo/global_burden_disease/projections2004/en/
3.https://migraine.com/infographic/the-hidden-cost-of-care/

More Less

Nov 3, 2017

WAT Med Will Display EmeTerm and HeadaTerm at MEDICA 2017 in Dusseldorf

VANCOUVER, British Columbia, Nov. 3, 2017 /PRNewswire/
WAT Med will take part in the world's leading trade fair for the medical industry, MEDICA in Dusseldorf from 13 - 16 November 2017

WAT Med is a company that develops safe, effective, and user-friendly smart medical technological products. The current products primarily target two common medical conditions: nausea-induced vomiting and primary migraines.

WAT Med's leading products:
EmeTerm™: An anti-nausea wristband stimulates the central nervous system with the electrical impulses through the median nerve to control gastric contractions and stop vomiting signals from the brain. EemTerm™ provides a sufficient solution for motion sickness, morning sickness and medicine induced nausea and vomiting.

HeadaTerm™: An anti-migraine headband that uses electrical impulses to activate the opioid receptors in the central nervous system to relieve natural opiates in the body and decreases the migraine sensation. World's 1st disposable anti-migraine device. The most portable and affordable.

Safety is the top priority of WAT Med leading products and all the materials of the device meet medical standards. Both EmeTerm™ and HeadaTerm™ use medical silicone, instead of natural rubber, making the device hypoallergenic and avoiding skin irritation. The patented electrodes design mode enhances the electric conduction and no conduction gel with potentially allergenic chemical compounds is needed.

Both EmeTerm™ and HeadaTerm™ are CE marked class II medical device.
EmeTerm™ is the winner of iF Design Award 2017.
The manufacturer, WAT Medical Enterprise Ltd., is certified to the ISO 13485 medical standard.

For more information, please visit WAT Medical Enterprise Ltd.'s website at www.watmedical.com or email info@watmedical.com.

References:

Shealy CN. Transcutaneous electrical nerve stimulation: the treatment of choice for pain and depression. J Altern Complement Med. 2003 Oct,9(5):619-23.
Kirsch DL, Nichols F. Cranial electrotherapy stimulation for treatment of anxiety, depression, and insomnia.  Psychiatr Clin North Am. 2013 Mar;36(1):169-76.
Schoenen J, Vandersmissen B, Jeangette S, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology.  2013 Feb 19;80(8):697-704.
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting Anesthesia & An al gesia January 2014 -Volume 118 - Issue 1- p 85-113
Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull. 1998 Nov 15;47(5):395-406
Streitberger K, Ezzo J, Schneider A. Acupuncture for nausea and vomiting: an update of clinical and experimental studies Auton Neurosci. 2006 Oct 30;129 (1-2):107-17
Schmal F. Neuronal mechanisms and the treatment of motion sickness. Pharmacology. 2013;91(3-4):229-41

More Less

Jul 28, 2017

EmeTerm(TM) Offers Solution to VR Motion Sickness

VANCOUVER, British Columbia, June 6, 2017 /PRNewswire/

-- Researchers have recently confirmed that virtual reality headsets tend to cause a form of motion sickness known as VR sickness, which induces nausea and vomiting. While developmental teams have tried to combat this issue, its prevalence remains common. Many in the industry fear that this will be a major obstacle for virtual reality to be adopted to the general public.

WAT Med attended LifeSciences BC's Health Networking event on May 17th and had the pleasure to meet Dr. Robert DiRaddo, the Section Head of Simulation and Digital Health at the National Research Council of Canada (NRC). Dr. DiRaddo's team develops mathematically-based interactive virtual reality and artificial intelligence technology for a wide range of uses, including neurosurgical training for surgeons, flying training for pilots, and anxiety control for airplane passengers.

Dr. DiRaddo expressed his interest in WAT Med's leading product, EmeTerm™, as a potential solution to motion sickness-induced vomiting. EmeTerm™'s innovative design and usability has received positive feedback from many other medical professionals at the event. EmeTerm™ is winner of iF Design Award 2017 with high level water-resist, magnetic recharging system, ergonomics design and medical level materials.

WAT Med remains in contact with NRC and are looking forward to offer solution for VR sickness and for other collaboration opportunities.

Company: WAT Medical Enterprise Ltd.
Website: www.watmedical.com
Email: info@watmedical.com

More Less

Jun 30, 2017

With EmeTerm(TM), Pregnant Women Don't Have to Suffer from Morning Sickness

VANCOUVER, British Columbia,June 30, 2017/PRNewswire/  -- Morning sickness affects 70-80% of all pregnant women.About 60% of them experience nausea and vomiting. Morning sickness can decrease pregnant women's work efficiency, result in unnecessary healthcare expenses, and negatively impact the quality of life of both the mothers and the unborn children. Some women even choose to have an abortion due to the severity of the symptoms.

One of the worst drug disasters in history resulted from an attempt to cease morning sickness with medications. Thalidomide, sold under the name, Immunoprin, was an anti-morning sickness drug used in the 1950s. This resulted in about 10,000 cases of infants who were born with phocomelia (the underdevelopment or absent of limbs and vital organs); only 50% of the 10,000 infants survived. While many modern medications are used today with low risk factors, they often contain debilitating side-effects.

EmeTerm™ is a drug free, none-invasive, and precise neuronal electrical stimulation technology that prevents and relieves morning sickness. By releasing a particular low-frequency electrical pulse from the user's wrist, EmeTerm™ adjusts the vagus nerve signals traveling to and from the stomach. This prevents or postpones the brain from transmitting nausea signals to the stomach. This then slows down the nausea-inducing irregular gastric contraction, and reduces the nauseous sensation for the users.

Safety is the number one priority of EmeTerm™. All the materials of the device meet medical standards. EmeTerm™ uses medical silicone, instead of natural rubber, making the device hypoallergenic. Inert metal is used in electrodes to avoid skin irritation. The patented electrodes are parallel with tendon, which enhances the electric conduction and no conduction gel with potentially allergenic chemical compounds is needed.

EmeTerm is CE marked class II medical device.
EmeTerm is winner of iF Design Award 2017. 
The manufacturer,WAT Medical Enterprise Ltd., is certified to the ISO 13485 medical standard.

For more information, please visit WAT Medical Enterprise Ltd.'s website at www.watmedical.com or email info@watmedical.com.

References:

al-Sadi M, Newman B, Julious SA. Acupuncture in the prevention of postoperative nausea and vomiting. Anaesthesia. 1997 Jul;52(7):658-61.

ates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull. 1998 Nov 15;47(5):395-406.

Takahashi T. Acupuncture for functional gastrointestinal disorders. J Gastroenterol. 2006 May;41(5):408-17.

Streitberger K, Ezzo J, Schneider A. Acupuncture for nausea and vomiting: an update of clinical and experimental studies. Auton Neurosci. 2006 Oct 30;129(1-2):107-17.

Schmäl F. Neuronal mechanisms and the treatment of motion sickness. Pharmacology. 2013;91(3-4):229-41.

More Less

About us

Company details

WAT Med is a company which focuses on the development of precise, wearable and smart medical products. With the devoted and leading it owns staff in the field of medical research and development, an efficient and convenient medical service is being provided for worldwide individual customers.Our mission: supplying innovative self-care medical device.

More Less